These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33328332)

  • 21. Attenuation of Wnt/β-catenin signaling in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Chen CB; Chang WC; Wu MY; Kao TY; Wang YW; Wang CW; Chen CJ; Chung WH; Su SC
    Int J Biol Sci; 2020; 16(2):353-364. PubMed ID: 31929762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding.
    French LE
    Allergol Int; 2006 Mar; 55(1):9-16. PubMed ID: 17075281
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    López-Rosas I; López-Camarillo C; Salinas-Vera YM; Hernández-de la Cruz ON; Palma-Flores C; Chávez-Munguía B; Resendis-Antonio O; Guillen N; Pérez-Plasencia C; Álvarez-Sánchez ME; Ramírez-Moreno E; Marchat LA
    Front Cell Infect Microbiol; 2018; 8():437. PubMed ID: 30671387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical expression of apoptotic markers in drug-induced erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Marzano AV; Frezzolini A; Caproni M; Parodi A; Fanoni D; Quaglino P; Girgenti V; La Placa M; Fabbri P; Caputo R; Berti E
    Int J Immunopathol Pharmacol; 2007; 20(3):557-66. PubMed ID: 17880768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutant GNLY is linked to Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Fonseca DJ; Caro LA; Sierra-Díaz DC; Serrano-Reyes C; Londoño O; Suárez YC; Mateus HE; Bolívar-Salazar D; Ramírez AF; de-la-Torre A; Laissue P
    Hum Genet; 2019 Dec; 138(11-12):1267-1274. PubMed ID: 31642954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recent progress in research of pathogeneses of Stevens-Johnson syndrome and toxic epidermal necrolysis].
    Gao TT; Long Q
    Zhonghua Yan Ke Za Zhi; 2016 Sep; 52(9):708-13. PubMed ID: 27647252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible involvement of CD14+ CD16+ monocyte lineage cells in the epidermal damage of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Tohyama M; Watanabe H; Murakami S; Shirakata Y; Sayama K; Iijima M; Hashimoto K
    Br J Dermatol; 2012 Feb; 166(2):322-30. PubMed ID: 21936856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recovered patients with Stevens-Johson syndrome and toxic epidermal necrolysis maintain long-lived IFN-γ and sFasL memory response.
    Fu M; Gao Y; Pan Y; Li W; Liao W; Wang G; Li C; Li C; Gao T; Liu Y
    PLoS One; 2012; 7(9):e45516. PubMed ID: 23029066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis.
    Chung WH; Hung SI
    J Dermatol Sci; 2012 Jun; 66(3):190-6. PubMed ID: 22541332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial cell apoptosis in severe drug-induced bullous eruptions.
    Verneuil L; Ratajczak P; Allabert C; Leboeuf C; Comoz F; Janin A; Ameisen JC
    Br J Dermatol; 2009 Dec; 161(6):1371-5. PubMed ID: 19575754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
    Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
    Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. XIAP, commonly targeted by tumor suppressive miR-3607-5p and miR-3607-3p, promotes proliferation and inhibits apoptosis in hepatocellular carcinoma.
    Lou W; Chen J; Ding B; Fan W
    Genomics; 2021 May; 113(3):933-945. PubMed ID: 33588071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological response in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Abe R
    J Dermatol; 2015 Jan; 42(1):42-8. PubMed ID: 25355273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of IL-13, IL-15 and Granulysin in the Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
    Sadek M; Iqbal O; Siddiqui F; Till S; Mazariegos M; Campbell E; Mudaliar K; Speiser J; Bontekoe E; Kouta A; Farooqui A; Daravath B; Qneibi D; Sadek R; Hoppensteadt D; Fareed J; Bouchard C
    Clin Appl Thromb Hemost; 2021; 27():1076029620950831. PubMed ID: 33560872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis--A Comprehensive Review and Guide to Therapy. I. Systemic Disease.
    Kohanim S; Palioura S; Saeed HN; Akpek EK; Amescua G; Basu S; Blomquist PH; Bouchard CS; Dart JK; Gai X; Gomes JA; Gregory DG; Iyer G; Jacobs DS; Johnson AJ; Kinoshita S; Mantagos IS; Mehta JS; Perez VL; Pflugfelder SC; Sangwan VS; Sippel KC; Sotozono C; Srinivasan B; Tan DT; Tandon R; Tseng SC; Ueta M; Chodosh J
    Ocul Surf; 2016 Jan; 14(1):2-19. PubMed ID: 26549248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
    J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Hasegawa A; Abe R
    F1000Res; 2020; 9():. PubMed ID: 32595945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulated lncRNA SBF2-AS1 in M2 macrophage-derived exosomes elevates miR-122-5p to restrict XIAP, thereby limiting pancreatic cancer development.
    Yin Z; Zhou Y; Ma T; Chen S; Shi N; Zou Y; Hou B; Zhang C
    J Cell Mol Med; 2020 May; 24(9):5028-5038. PubMed ID: 32301277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stem cells derived exosomal miR-323-3p promotes proliferation and inhibits apoptosis of cumulus cells in polycystic ovary syndrome (PCOS).
    Zhao Y; Tao M; Wei M; Du S; Wang H; Wang X
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3804-3813. PubMed ID: 31549864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repression of miR-142-3p alleviates psoriasis-like inflammation by repressing proliferation and promoting apoptosis of keratinocytes via targeting Sema3A.
    Zhang D; Wang Y; Xia Y; Huo J; Zhang Y; Yang P; Zhang Y; Wang X
    Mol Cell Probes; 2020 Aug; 52():101573. PubMed ID: 32325105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.